Semler Scientific develops and markets innovative medical technology to support the early detection of chronic diseases, particularly Peripheral Arterial Disease (PAD). Their core product, QuantaFlo, offers providers a portable and easy-to-use solution for point-of-care PAD assessment. The company aims to transform healthcare by enabling earlier diagnosis and better management of chronic conditions.